Squarepoint
TXG icon

Squarepoint’s 10x Genomics TXG Stock Holding History

Squarepoint’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Buy
+53,966
New +$1.41M ﹤0.01% 2319
2026
Q1 		– Sell
-27,850
Closed -$454K – 4997
2025
Q4 		$454K Buy
+27,850
New +$421K ﹤0.01% 3289
2025
Q2 		– Sell
-274,743
Closed -$2.4M – 5075
2025
Q1 		$2.4M Sell
274,743
-315,767
-53% -$3.98M ﹤0.01% 1949
2024
Q4 		$8.48M Sell
590,510
-121,729
-17% -$1.92M 0.01% 1258
2024
Q3 		$16.1M Buy
712,239
+196,356
+38% +$4.06M 0.03% 696
2024
Q2 		$10M Buy
515,883
+5,720
+1% +$150K 0.02% 943
2024
Q1 		$19.1M Buy
510,163
+270,788
+113% +$11.9M 0.03% 634
2023
Q4 		$13.4M Sell
239,375
-215,744
-47% -$9.39M 0.03% 778
2023
Q3 		$18.8M Buy
455,119
+338,311
+290% +$17.6M 0.05% 486
2023
Q2 		$6.52M Buy
116,808
+109,519
+1,503% +$5.93M 0.02% 926
2023
Q1 		$407K Sell
7,289
-2,202
-23% -$103K ﹤0.01% 2412
2022
Q4 		$346K Sell
9,491
-33,556
-78% -$1.1M ﹤0.01% 2492
2022
Q3 		$1.23M Buy
+43,047
New +$1.64M 0.01% 1619
2022
Q1 		– Sell
-4,175
Closed -$622K – 3548
2021
Q4 		$622K Buy
+4,175
New +$639K ﹤0.01% 2005
2021
Q1 		– Sell
-44,709
Closed -$6.33M – 3636
2020
Q4 		$6.33M Buy
44,709
+42,359
+1,803% +$6.15M 0.05% 383
2020
Q3 		$293K Sell
2,350
-944
-29% -$99.1K ﹤0.01% 1811
2020
Q2 		$294K Buy
+3,294
New +$257K ﹤0.01% 1617

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Squarepoint's TXG Position: Q2 2026 in Review

Squarepoint opened a new position in 10x Genomics (TXG) in Q2 2026: 53,966 shares worth $2.07M. The stake represents ﹤0.01% of the portfolio and ranks #2319 among its holdings. This is a return to the name: Squarepoint previously reported a position in TXG as recently as Q4 2025.

Squarepoint first reported a position in TXG in Q2 2020 and has held it in 17 quarters since. The position peaked at $19.1M in Q1 2024. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Squarepoint held 53,966 shares of 10x Genomics worth $2.07M as of Q2 2026.
  • 10x Genomics was a new Squarepoint position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2319 holding.
  • Squarepoint first reported a position in 10x Genomics in Q2 2020 and has held it in 17 quarters since.
  • Squarepoint's 10x Genomics position peaked at $19.1M in Q1 2024.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.